Literature DB >> 18812710

Surgical treatment of angiosarcoma of the scalp: less is more.

Alexandra Buschmann1, Marcus Lehnhardt, Nidal Toman, Peter Preiler, M Sedigh Salakdeh, Thomas Muehlberger.   

Abstract

Angiosarcomas (AS) of the scalp are rare tumors with an extremely poor prognosis mostly affecting elderly patients. Given the special anatomic nature of the blood supply to the scalp, it must be presumed that the tumor has already spread at the time of the initial presentation. We report a simple and fast surgical procedure, which places only a minimum burden on the patient. In 19 patients, we performed a resection of the external table with the defect being covered immediately by a split skin graft. The average stay in hospital amounted to 12.2 days. The postoperative period free of recurrences was 2.7 months on average. The average survival period after resection was 17.5 months. In view of the difficult diagnosis, an often delayed therapy and the rapid formation of metastases, a time-saving procedure with a low rate of complications should be given preference over other reconstructive methods.

Entities:  

Mesh:

Year:  2008        PMID: 18812710     DOI: 10.1097/SAP.0b013e31816b31f8

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  11 in total

1.  Cutaneous angiosarcoma of the head and face: a single-center analysis of treatment outcomes in 43 patients in Japan.

Authors:  Takamichi Ito; Hiroshi Uchi; Takeshi Nakahara; Gaku Tsuji; Yoshinao Oda; Akihito Hagihara; Masutaka Furue
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-25       Impact factor: 4.553

2.  Cutaneous angiosarcoma: a single-institution experience.

Authors:  Matthew C Perez; Tapan A Padhya; Jane L Messina; Ryan S Jackson; Ricardo J Gonzalez; Marilyn M Bui; G Douglas Letson; C W Cruse; Robert S Lavey; David Cheong; Meghan R Forster; William J Fulp; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2013-07-09       Impact factor: 5.344

3.  Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp.

Authors:  B Ashleigh Guadagnolo; Gunar K Zagars; Dejka Araujo; Vinod Ravi; Thomas D Shellenberger; Erich M Sturgis
Journal:  Head Neck       Date:  2010-10-19       Impact factor: 3.147

4.  Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT.

Authors:  Devarati Mitra; Yaguang Pei; Ivan Buzurovic; Phillip M Devlin; Katherine Thornton; Chandrajit P Raut; Elizabeth H Baldini; Miranda B Lam
Journal:  Sarcoma       Date:  2020-08-25

5.  Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.

Authors:  Kevin C Lee; Sung-Kiang Chuang; Elizabeth M Philipone; Scott M Peters
Journal:  Head Neck Pathol       Date:  2018-10-24

6.  Radiation therapy for angiosarcoma of the scalp: treatment outcomes of total scalp irradiation with X-rays and electrons.

Authors:  Masaharu Hata; Hidefumi Wada; Ichiro Ogino; Motoko Omura; Izumi Koike; Yoshibumi Tayama; Kazumasa Odagiri; Takeo Kasuya; Tomio Inoue
Journal:  Strahlenther Onkol       Date:  2014-03-13       Impact factor: 3.621

7.  Surgical Treatment and Prognosis of Angiosarcoma of the Scalp: A Retrospective Analysis of 14 Patients in a Single Institution.

Authors:  Jun Ho Choi; Kyung Chan Ahn; Hak Chang; Kyung Won Minn; Ung Sik Jin; Byung Jun Kim
Journal:  Biomed Res Int       Date:  2015-12-02       Impact factor: 3.411

8.  The prognostic value of pretreatment inflammatory biomarkers in primary angiosarcoma.

Authors:  Manni Wang; Shuang Wu; An Tong; Xiwei Cui; Xuelei Ma
Journal:  Cancer Manag Res       Date:  2019-08-22       Impact factor: 3.989

9.  Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face.

Authors:  Devarati Mitra; Phillip M Devlin; Ivan Buzurovic; Katherine Thornton; Allen C Lam; Chandrajit P Raut; Elizabeth H Baldini; Miranda B Lam
Journal:  J Contemp Brachytherapy       Date:  2021-04-14

Review 10.  Cutaneous Angiosarcoma: The Possibility of New Treatment Options Especially for Patients with Large Primary Tumor.

Authors:  Yasuhiro Fujisawa; Koji Yoshino; Taku Fujimura; Yoshiyuki Nakamura; Naoko Okiyama; Yosuke Ishitsuka; Rei Watanabe; Manabu Fujimoto
Journal:  Front Oncol       Date:  2018-03-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.